Rüdiger Martin Groß

University Hospital Ulm

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Miriam Deniz

University Hospital Ulm

GERMANY

View details

Eva Herker

Professor

Philipps-Universität Marburg

GERMANY

View details

Luigi Aurisicchio

Chief Executive Officer

ITALY

View details

Barbara Müller

PI/Prof.Dr.

University Hospital Heidelberg

GERMANY

View details

Ulrich Rothbauer

Professor

Eberhard Karls Universität Tübingen

GERMANY

View details

Giuseppe Roscilli

Chief Technology Officer and Director

ITALY

View details

Anneke Haddad

University Medical Center Freiburg

GERMANY

View details

Janis A Müller

Philipps-Universität Marburg

GERMANY

View details

Marta Rizzi

University Medical Center Freiburg

GERMANY

View details

Elke Pogge von Strandmann

GERMANY

View details

Konstantin MJ Sparrer

Ulm University

GERMANY

View details

Alexander Kleger

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rüdiger Martin Groß

Research Interests

Explore related searches

Contact this professor

Articles (13)

Transduction enhancing EF-C peptide nanofibrils are endocytosed by macropinocytosis and subsequently degraded

Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens.

Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection

Robust and durable serological response following pediatric SARS-CoV-2 infection

COVID-19 and diabetes — where are we now?

Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses.

Actin cytoskeleton remodeling primes RIG-I-like receptor activation.

Utilization of Aminoguanidine Prevents Cytotoxic Effects of Semen.

BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults.

Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2.

Towards the direct detection of viral materials at the surface of protective face masks via infrared spectroscopy.

Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS-CoV-2 Spike.

Collaborators (12)

Miriam Deniz

Eva Herker

Luigi Aurisicchio

Barbara Müller

Ulrich Rothbauer

Giuseppe Roscilli

Anneke Haddad

Janis A Müller

Marta Rizzi

Elke Pogge von Strandmann

Konstantin MJ Sparrer

Alexander Kleger

Make your next move.